Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

INTRODUCTION: Circulating tumor cells (CTC) have been recently proposed as a new dynamic blood marker whose positivity at baseline is a prognostic factor and whose changes under treatment are correlated with progression-free survival (PFS) in metastatic breast cancer patients. However, serum marker...

Descripción completa

Detalles Bibliográficos
Autores principales: Bidard, François-Clément, Hajage, David, Bachelot, Thomas, Delaloge, Suzette, Brain, Etienne, Campone, Mario, Cottu, Paul, Beuzeboc, Philippe, Rolland, Emilie, Mathiot, Claire, Pierga, Jean-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496147/
https://www.ncbi.nlm.nih.gov/pubmed/22330883
http://dx.doi.org/10.1186/bcr3114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496147/
https://www.ncbi.nlm.nih.gov/pubmed/22330883
http://dx.doi.org/10.1186/bcr3114

Ejemplares similares